Citadel Advisors
KRMD icon

Citadel Advisors’s KORU Medical Systems KRMD Stock Holding History

Citadel Advisors’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,800
Closed -$45.4K – 15082
2024
Q4 		$45.4K Buy
11,800
+8,000
+211% +$26K ﹤0.01% 12486
2024
Q3 		$10.4K Buy
3,800
+3,500
+1,167% +$8.63K ﹤0.01% 13208
2024
Q2 		$795 Buy
+300
New +$686 ﹤0.01% 13912
2024
Q1 		– Sell
-1,300
Closed -$3.19K – 15066
2023
Q4 		$3.19K Sell
1,300
-1,200
-48% -$2.86K ﹤0.01% 13620
2023
Q3 		$6.75K Buy
2,500
+1,100
+79% +$3.01K ﹤0.01% 13302
2023
Q2 		$4.83K Sell
1,400
-200
-13% -$785 ﹤0.01% 13566
2023
Q1 		$6.75K Buy
1,600
+1,500
+1,500% +$5.9K ﹤0.01% 13779
2022
Q4 		$357 Buy
+100
New +$276 ﹤0.01% 14685
2021
Q3 		– Sell
-27,300
Closed -$126K – 14268
2021
Q2 		$126K Sell
27,300
-12,700
-32% -$49.9K ﹤0.01% 12693
2021
Q1 		$141K Buy
40,000
+14,900
+59% +$64.5K ﹤0.01% 12122
2020
Q4 		$151K Buy
25,100
+13,800
+122% +$77.2K ﹤0.01% 9937
2020
Q3 		$82K Buy
+11,300
New +$100K ﹤0.01% 9380

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Citadel Advisors's KRMD Position: Q2 2026 in Review

Citadel Advisors reduced its KORU Medical Systems (KRMD) stake by 41% in Q2 2026, selling an estimated $82.8K and leaving 28,520 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #12537.

Citadel Advisors first reported a position in KRMD in Q3 2020 and has held it in 20 quarters since. The position peaked at $464K in Q4 2020. 84 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Citadel Advisors held 28,520 shares of KORU Medical Systems worth $120K as of Q2 2026.
  • Citadel Advisors sold 20,206 KORU Medical Systems shares in Q2 2026, an estimated $82.8K.
  • KORU Medical Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12537 holding.
  • Citadel Advisors first reported a position in KORU Medical Systems in Q3 2020 and has held it in 20 quarters since.
  • Citadel Advisors's KORU Medical Systems position peaked at $464K in Q4 2020.
  • 84 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.